Skip to main content
Nilofer Azad, MD, Oncology, Baltimore, MD

NiloferSabaAzadMD

Oncology Baltimore, MD

Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Dr. Azad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Azad's full profile

Already have an account?

  • Office

    201 North Broadway Street
    Viragh BLDG 5th FL
    Baltimore, MD 21287
    Phone+1 410-955-8964
    Fax+1 410-367-2194

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2001 - 2004
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2001

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2008 - 2026
  • PA State Medical License
    PA State Medical License 2004 - 2024
  • VA State Medical License
    VA State Medical License 2005 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • DC State Medical License
    DC State Medical License 2013 - 2016
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • What Is Working in Clinical Trial Recruitment? - Panel Moderator 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

  • Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
    Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 15th, 2024
  • Drug Combination Boosts Immune Response in Resistant Pancreatic Cancers
    Drug Combination Boosts Immune Response in Resistant Pancreatic CancersNovember 15th, 2024
  • Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
    Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 14th, 2024
  • Join now to see all

Committees

  • Member, Committee on Appropriateness Criteria, Expert Panel on Interventional Radiology, American College of Radiology 2015 - Present

Other Languages

  • Urdu, Hindi